Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study

AA Elfiky - Life sciences, 2020 - Elsevier
Aims A new human coronavirus (HCoV), which has been designated SARS-CoV-2, began
spreading in December 2019 in Wuhan City, China causing pneumonia called COVID-19 …

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

AA Elfiky - Life sciences, 2020 - Elsevier
Aims A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan,
China (COVID-19). Until today> 2700 deaths from the 80,000 confirmed cases reported …

SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective

AA Elfiky - Journal of Biomolecular Structure and Dynamics, 2021 - Taylor & Francis
New treatment against SARS-CoV-2 now is a must. Nowadays, the world encounters a huge
health crisis by the COVID-19 viral infection. Nucleotide inhibitors gave a lot of promising …

Structure-based drug design of RdRp inhibitors against SARS-CoV-2

K Shehzadi, A Saba, M Yu, J Liang - Topics in Current Chemistry, 2023 - Springer
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
worldwide pandemic since 2019, spreading rapidly and posing a significant threat to human …

Emerging quinoline‐and quinolone‐based antibiotics in the light of epidemics

P Kaur, Anuradha, A Chandra, T Tanwar… - Chemical Biology & …, 2022 - Wiley Online Library
Pandemics are large‐scale outbreaks of infectious disease that can greatly increase
morbidity and mortality all the globe. Since past 1990 till twentieth century, these infectious …

Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective

AA Elfiky, EB Azzam - Journal of Biomolecular Structure and …, 2021 - Taylor & Francis
Abstract The Middle East Respiratory Syndrome Coronavirus (MERS CoV), also termed
camel flu, is a new viral infection that first reported in the year 2012 in the Middle East region …

Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods

A Poustforoosh, H Hashemipour, B Tüzün… - Biophysical …, 2021 - Elsevier
Introduction Despite all the efforts to treat COVID-19, no particular cure has been found for
this virus. Since developing antiviral drugs is a time-consuming process, the most effective …

Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors

WB Cardoso, SA Mendanha - Journal of molecular structure, 2021 - Elsevier
In this paper we investigate 10 different HIV protease inhibitors (HPIs) as possible
repurposed-drugs candidates against SARS-CoV-2. To this end, we execute molecular …

[HTML][HTML] Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach

SA Mir, A Firoz, M Alaidarous, B Alshehri… - Saudi Journal of …, 2022 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19), which emerged in December 2019,
continues to be a serious health concern worldwide. There is an urgent need to develop …

Antiviral activities of olive oil apigenin and taxifolin against SARS-CoV-2 RNA-dependent RNA polymerase (RdRP): In silico, pharmacokinetic, ADMET, and in-vitro …

S Selim, M Albqmi, A Alanazi, Y Alruwaili… - Cogent Food & …, 2023 - Taylor & Francis
A novel coronavirus strain called SARS-CoV-2 first appeared in China in December 2019.
Natural products are significant sources of prospective and new antiviral medications, and …